Physician profile
Christy Powell
NPI 1093228991
$2,400.63
in general payments reported to CMS, 2019-2025
16 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $612 · 2022: $160 · 2023: $390 · 2024: $966 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,629.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $980.74 | 2021-2025 | Jardiance |
| Novo Nordisk INC | $242.38 | 2022-2024 | Wegovy |
| Janssen Pharmaceuticals, INC | $233.29 | 2021-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $196.73 | 2024 | Assure Wcd |
| Cvrx, INC. | $170.58 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $140.09 | 2021-2025 | Lokelma |
| Medtronic, INC. | $89.75 | 2023 | Linq II |
| Abbott Laboratories | $82.95 | 2021-2022 | |
| Impulse Dynamics (USA) INC. | $63.82 | 2022-2023 | Optimizer |
| Novartis Pharmaceuticals Corporation | $44.30 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $39.98 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $32.87 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $31.97 | 2025 | Uptravi |
| Bayer Healthcare Pharmaceuticals INC. | $21.73 | 2021 | |
| Pfizer INC. | $15.95 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $13.50 | 2023 | Edarbi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christy Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.